- Cantel’s stock has momentum over the long-term.
- The company is achieving strong growth in its largest segments.
- The stock should continue to beat the S&P 500 driven by its above average earnings growth.
Cantel Medical Corporation is a provider of infection prevention and control products in the healthcare market. Its operating segments include: Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis, and Specialty Packaging.